Yinyin Devoe, MD
Pain Medicine · Tulsa, OKNPI 1427192434
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Abbott at 37.8% of the total. Reporting peaked in 2019 at $1,060 and has fallen 80.2% since, to $210 in 2024. That places this record below the midpoint for pain medicine clinicians in OK, where the typical reported total is $1,721.
Across 31 payments — averaging $48.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$566
- Biodelivery Sciences International, Inc.$150
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$146
- Teva Pharmaceuticals USA, Inc.$142
- GRT US Holding, Inc.$121
- Edwards Lifesciences$95
- plus $277 from 7 others
What the payments were for
- Food & beverage$1,497100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 5 | $566 |
| Biodelivery Sciences International, Inc. | 2 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $146 |
| Teva Pharmaceuticals USA, Inc. | 2 | $142 |
| GRT US Holding, Inc. | 2 | $121 |
| Edwards Lifesciences | 1 | $95 |
| Pfizer | 3 | $88 |
| AbbVie | 6 | $86 |
| Daiichi Sankyo Inc. | 3 | $50 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$341
- AJOVY$134
- XIFAXAN$115
- Qutenza$114
- Octrode SCS Leads$105
How this compares
$1,497 in reported general payments places this provider in the 45th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 49 | $40,865 |
| Buprenorphine | 149 | $31,618 |
| Nucynta ErTapentadol Hcl | 22 | $16,473 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 508 | $14,676 |
| Xtampza ErOxycodone Myristate | 12 | $10,605 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 73 | $7,331 |
| Buprenorphine Hcl | 149 | $5,049 |
| Pregabalin | 175 | $4,706 |
| Lidocaine | 13 | $4,562 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 213 | $3,414 |
| ButransBuprenorphine | 14 | $3,371 |
| Naloxone Hcl | 53 | $3,166 |
| Lubiprostone | 15 | $2,999 |
| Gabapentin | 123 | $2,470 |
| Baclofen | 123 | $2,031 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Tulsa
- Brian TorgersonTulsa$13K
- Lam NguyenTulsa$11K
- Jayen PatelTulsa$10K
- Hugo SalgueroTulsa$10K
- Adam WallaceTulsa$8K
- Kenneth ReedTulsa$7K
- Ahmad KhattabTulsa$7K
- David DoTulsa$6K
- Emad Attallah-WasifTulsa$4K
- Leslie ChanTulsa$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.